In vivo assessment of high-grade glioma biochemistry using microdialysis: A study of energy-related molecules, growth factors and cytokines

Journal of Neuro-Oncology

Volumn 97, Issue 1, 2010, Pages 11-23

  Marcus, Hani J ^a   Carpenter, Keri L H ^a   Price, Stephen J ^a   Hutchinson, Peter J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cytokines; Energy metabolism; Glioma; Growth factors; Microdialysis

Indexed keywords

DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; GLUTAMIC ACID; GLYCEROL; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PYRUVIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; BRAIN SURGERY; CLINICAL ARTICLE; EXTRACELLULAR FLUID; FEMALE; GLIOBLASTOMA; GLIOMA; GLUCOSE BRAIN LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROSURGERY; TRAUMATIC BRAIN INJURY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CYTOKINES; DEXAMETHASONE; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLUCOSE; GLUTAMIC ACID; GLYCEROL; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LACTIC ACID; MALE; MATRIX METALLOPROTEINASE 9; MICRODIALYSIS; MIDDLE AGED; PYRUVIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 77949266026     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9990-5     Document Type: Article

References (75)

1. U Ungerstedt C Pycock 1974 Functional correlates of dopamine neurotransmission Bull Schweiz Akad Med Wiss 30 44 55 1:CAS:528: DyaE2cXlsVyqsL0%3D 4371656
2. L Persson L Hillered 1992 Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis J Neurosurg 76 72 80 10.3171/jns.1992.76.1.0072 1:STN:280:DyaK38%2FnvFSntw%3D%3D 1727172
3. H Landolt H Langemann 1996 Cerebral microdialysis as a diagnostic tool in acute brain injury Eur J Anaesthesiol 13 269 278 10.1097/00003643-199605000- 00005 1:STN:280:DyaK28zks1Oquw%3D%3D 8737118
4. L Persson J Valtysson P Enblad PE Warme K Cesarini A Lewen L Hillered 1996 Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage J Neurosurg 84 606 616 10.3171/jns.1996.84.4.0606 1:STN:280:DyaK287otVagtg%3D%3D 8613852
5. MJ During DD Spencer 1993 Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain Lancet 341 1607 1610 10.1016/0140-6736(93)90754-5 1:STN:280:DyaK3s3psFWmsg%3D%3D 8099987 (Pubitemid 23175242)
6. M Roslin R Henriksson P Bergstrom U Ungerstedt AT Bergenheim 2003 Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis J Neurooncol 61 151 160 10.1023/A:1022106910017 12622454 (Pubitemid 36253661)
7. A Klegeris DG Walker PL McGeer 1997 Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells J Neuroimmunol 78 152 161 10.1016/S0165-5728(97)00094-5 1:CAS:528:DyaK2sXkvVaqtrY%3D 9307240 (Pubitemid 27394437)
8. PF Behrens H Langemann R Strohschein J Draeger J Hennig 2000 Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study J Neurooncol 47 11 22 10.1023/A:1006426917654 1:STN:280:DC%2BD3M%2FktV2itw%3D%3D 10930095 (Pubitemid 30458401)
9. J Hillman O Aneman M Persson C Andersson C Dabrosin P Mellergard 2007 Variations in the response of interleukins in neurosurgical intensive care patients monitored using intracerebral microdialysis J Neurosurg 106 820 825 10.3171/jns.2007.106.5.820 1:CAS:528:DC%2BD2sXlsF2msb0%3D 17542525 (Pubitemid 46698667)
10. PJ Hutchinson MT O'Connell NJ Rothwell SJ Hopkins J Nortje KLH Carpenter I Timofeev PG Al-Rawi DK Menon JD Pickard 2007 Inflammation in human brain injury: intracerebral concentrations of IL 1alpha, IL-1beta and their endogenous inhibitor IL-1ra J Neurotrauma 24 1545 1557 10.1089/neu.2007.0295 17970618 (Pubitemid 350035838)
11. J Hillman O Aneman C Anderson F Sjogren C Saberg P Mellergard 2005 A microdialysis technique for routine measurement of macromolecules in the injured human brain Neurosurgery 56 1264 1268 10.1227/01.NEU.0000159711.93592.8D 15918942 discussion 1268-1270 (Pubitemid 40770444)
12. T Flannery RS McConnell S McQuaid G McGregor M Mirakhur L Martin C Scott R Burden B Walker C McGoohan PG Johnston 2007 Detection of cathepsin S cysteine protease in human brain tumour microdialysates in vivo Br J Neurosurg 21 204 209 10.1080/02688690701248190 1:STN:280:DC%2BD2s3ksVGmug%3D%3D 17453790 (Pubitemid 46572895)
13. TA Libermann HR Nusbaum N Razon R Kris I Lax H Soreq N Whittle MD Waterfield A Ullrich J Schlessinger 1985 Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature 313 144 147 10.1038/313144a0 1:CAS:528:DyaL2MXhtVOgsbg%3D 2981413 (Pubitemid 15192341)
14. AJ Wong SH Bigner DD Bigner KW Kinzler SR Hamilton B Vogelstein 1987 Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification Proc Natl Acad Sci USA 84 6899 6903 10.1073/pnas.84.19.6899 1:CAS:528:DyaL1cXktVyq 3477813
15. SH Bigner B Vogelstein 1990 Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma Brain Pathol 1 12 18 10.1111/j.1750-3639. 1990.tb00633.x 1:STN:280:DyaK2c7it12htA%3D%3D 1669688
16. AJ Ekstrand CD James WK Cavenee B Seliger RF Pettersson VP Collins 1991 Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo Cancer Res 51 2164 2172 1:CAS:528:DyaK3MXisVWkurw%3D 2009534
17. T Gauthier MF Hamou L Monod P Gallay S Carrel N de Tribolet 1993 Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo Acta Neurochir (Wien) 121 199 205 10.1007/BF01809276 1:STN:280:DyaK3s3ovFyqug%3D%3D
18. M Tada AC Diserens I Desbaillets R Jaufeerally MF Hamou N de Tribolet 1994 Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivo J Neuroimmunol 50 187 194 10.1016/0165-5728(94)90045-0 1:CAS:528:DyaK2cXivFKntr4%3D 8120140 (Pubitemid 24071784)
19. SE Ilyin I Gonzalez-Gomez A Romanovicht D Gayle FH Gilles CR Plata-Salaman 2000 Autoregulation of the interleukin-1 system and cytokine-cytokine interactions in primary human astrocytoma cells Brain Res Bull 51 29 34 10.1016/S0361-9230(99)00190-2 1:CAS:528:DC%2BD3cXjtFSmsQ%3D%3D 10654577 (Pubitemid 30029064)
20. E Oelmann A Kraemer H Serve B Reufi D Oberberg S Patt H Herbst H Stein E Thiel WE Berdel 1997 Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1 Int J Cancer 71 1066 1076 10.1002/(SICI)1097-0215(19970611)71: 6<1066::AID-IJC25>3.0.CO;2-A 1:CAS:528:DyaK2sXktVyrsb8%3D 9185713 (Pubitemid 27252892)
21. C Chang Z Werb 2001 The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis Trends Cell Biol 11 S37 S43 1:CAS:528:DC%2BD3MXnvFGrsb4%3D 11684441
22. EI Deryugina MA Bourdon GX Luo RA Reisfeld A Strongin 1997 Matrix metalloproteinase-2 activation modulates glioma cell migration J Cell Sci 110 2473 2482 1:CAS:528:DyaK2sXnt1Giurk%3D 9410885
23. K Komatsu Y Nakanishi N Nemoto T Hori T Sawada M Kobayashi 2004 Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas Brain Tumor Pathol 21 105 112 10.1007/BF02482184 1:CAS:528:DC%2BD2MXhtlSjsLzP 15696970 (Pubitemid 40187984)
24. K Lampert U Machein MR Machein W Conca HH Peter B Volk 1998 Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors Am J Pathol 153 429 437 1:CAS:528:DyaK1cXls1ejtro%3D 9708803
25. N Gagliano C Moscheni C Torri I Magnani AA Bertelli M Gioia 2005 Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells Biomed Pharmacother 59 359 364 10.1016/j.biopha.2005.06.001 1:CAS:528: DC%2BD2MXpslygsrg%3D 16084059 (Pubitemid 41219649)
26. K Kunishio M Okada Y Matsumoto S Nagao 2003 Matrix metalloproteinase-2 and -9 expression in astrocytic tumors Brain Tumor Pathol 20 39 45 10.1007/BF02483445 1:CAS:528:DC%2BD2sXjtF2js7o%3D 14756439 (Pubitemid 38146269)
27. A Hormigo B Gu S Karimi E Riedel KS Panageas MA Edgar MK Tanwar JS Rao M Fleisher LM DeAngelis EC Holland 2006 YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas Clin Cancer Res 12 5698 5704 10.1158/1078-0432.CCR-06-0181 1:CAS:528:DC%2BD28XhtVartbrE 17020973 (Pubitemid 44629598)
28. G Choe JK Park L Jouben-Steele TJ Kremen LM Liau HV Vinters TF Cloughesy PS Mischel 2002 Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype Clin Cancer Res 8 2894 2901 1:CAS:528: DC%2BD38XnvVWisbc%3D 12231534
29. R Beliveau L Delbecchi E Beaulieu N Mousseau Z Kachra F Berthelet R Moumdjian R Del Maestro 1999 Expression of matrix metalloproteinases and their inhibitors in human brain tumors Ann N Y Acad Sci 886 236 239 10.1111/j.1749-6632.1999.tb09425.x 1:CAS:528:DC%2BD3cXnt1ensA%3D%3D 10667228 (Pubitemid 30042447)
30. Z Kachra E Beaulieu L Delbecchi N Mousseau F Berthelet R Moumdjian R Del Maestro R Beliveau 1999 Expression of matrix metalloproteinases and their inhibitors in human brain tumors Clin Exp Metastasis 17 555 566 10.1023/A:1006760632766 1:CAS:528:DC%2BD3cXksl2mu7k%3D 10845554 (Pubitemid 30337129)
31. SK Chintala JC Tonn JS Rao 1999 Matrix metalloproteinases and their biological function in human gliomas Int J Dev Neurosci 17 495 502 10.1016/S0736-5748(99)00010-6 1:CAS:528:DC%2BD3cXhtlyqug%3D%3D 10571411 (Pubitemid 29421836)
32. LL Groft H Muzik NB Rewcastle RN Johnston V Knauper MA Lafleur PA Forsyth DR Edwards 2001 Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas Br J Cancer 85 55 63 10.1054/bjoc.2001.1854 1:CAS:528:DC%2BD3MXlvVKhtbo%3D 11437402 (Pubitemid 32695716)
33. M Nakada D Kita K Futami J Yamashita N Fujimoto H Sato Y Okada 2001 Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma J Neurosurg 94 464 473 10.3171/jns.2001.94.3.0464 1:CAS:528:DC%2BD3MXhvFKgtbk%3D 11235952
34. CY Chang MC Li SL Liao YL Huang CC Shen HC Pan 2005 Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme J Clin Neurosci 12 930 933 10.1016/j.jocn.2004.11.017 1:CAS:528:DC%2BD2MXht1OlsLbE 16326273 (Pubitemid 41744083)
35. I Fischer JP Gagner M Law EW Newcomb D Zagzag 2005 Angiogenesis in gliomas: biology and molecular pathophysiology Brain Pathol 15 297 310 1:CAS:528:DC%2BD2MXht12qt7zL 16389942
36. DJ Brat AC Bellail EG Van Meir 2005 The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis Neuro Oncol 7 122 133 10.1215/S1152851704001061 1:CAS:528:DC%2BD2MXjvV2qsLg%3D 15831231 (Pubitemid 40590513)
37. S Loeffler B Fayard J Weis J Weissenberger 2005 Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1 Int J Cancer 115 202 213 10.1002/ijc.20871 1:CAS:528:DC%2BD2MXjvFWjs78%3D 15688401 (Pubitemid 40586728)
38. PJ Hutchinson MT O'Connell PG Al-Rawi LB Maskell R Kett-White AK Gupta HK Richards DB Hutchinson PJ Kirkpatrick JD Pickard 2000 Clinical cerebral microdialysis: a methodological study J Neurosurg 93 37 43 10.3171/jns.2000.93. 1.0037 1:STN:280:DC%2BD3czjvV2lsA%3D%3D 10883903
39. GC Durkan JE Nutt C Marsh PH Rajjayabun MC Robinson DE Neal J Lunec JK Mellon 2003 Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer Clin Cancer Res 9 2576 2582 1:CAS:528:DC%2BD3sXlt1yrsr0%3D 12855633
40. K Gohji N Fujimoto A Fujii T Komiyama J Okawa M Nakajima 1996 Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection Cancer Res 56 3196 3198 1:CAS:528:DyaK28Xktlaqsb4%3D 8764105
41. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D 15758009 (Pubitemid 40349501)
42. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114 123 10.1056/NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D 11150363 (Pubitemid 32052502)
43. PJ Kelly C Daumas-Duport DB Kispert BA Kall BW Scheithauer JJ Illig 1987 Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms J Neurosurg 66 865 874 10.3171/jns.1987.66.6.0865 1:STN:280: DyaL2s7pslGqtw%3D%3D 3033172
44. SJ Price R Jena NG Burnet PJ Hutchinson AF Dean A Pena JD Pickard TA Carpenter JH Gillard 2006 Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study AJNR Am J Neuroradiol 27 1969 1974 1:STN:280:DC%2BD28ngslSntg%3D%3D 17032877
45. ME Berens A Giese 1999 ".those left behind". Biology and oncology of invasive glioma cells Neoplasia 1 208 219 10.1038/sj.neo.7900034 1:STN:280:DC%2BD3czpsVGhsQ%3D%3D 10935475
46. PR Luyten AJ Marien W Heindel PH van Gerwen K Herholz JA den Hollander G Friedmann WD Heiss 1990 Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET Radiology 176 791 799 1:STN:280: DyaK3czls1OrtA%3D%3D 2389038
47. MV Padma S Said M Jacobs DR Hwang K Dunigan M Satter B Christian J Ruppert T Bernstein G Kraus JC Mantil 2003 Prediction of pathology and survival by FDG PET in gliomas J Neurooncol 64 227 237 10.1023/A:1025665820001 1:STN:280:DC%2BD3svotVWgsQ%3D%3D 14558598 (Pubitemid 37203463)
48. L Ostergaard FH Hochberg JD Rabinov AG Sorensen M Lev L Kim RM Weisskoff RG Gonzalez C Gyldensted BR Rosen 1999 Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors J Neurosurg 90 300 305 10.3171/jns.1999.90.2.0300 1:STN:280:DyaK1M7jsVSjsg%3D%3D 9950501
49. K Herholz W Heindel PR Luyten JA denHollander U Pietrzyk J Voges H Kugel G Friedmann WD Heiss 1992 In vivo imaging of glucose consumption and lactate concentration in human gliomas Ann Neurol 31 319 327 10.1002/ana.410310315 1:STN:280:DyaK38zksVemsw%3D%3D 1637139
50. EC Lin 1977 Glycerol utilization and its regulation in mammals Annu Rev Biochem 46 765 795 10.1146/annurev.bi.46.070177.004001 1:CAS:528: DyaE2sXltFGisrk%3D 197882
51. Y Hayashi NA Edwards MA Proescholdt EH Oldfield MJ Merrill 2007 Regulation and function of aquaporin-1 in glioma cells Neoplasia 9 777 787 10.1593/neo.07454 1:CAS:528:DC%2BD2sXhtl2rtrzI 17898873 (Pubitemid 47523239)
52. AT Bergenheim M Roslin U Ungerstedt A Waldenstrom R Henriksson G Ronquist 2006 Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB) J Neurooncol 80 285 293 10.1007/s11060-006-9186-1 1:CAS:528:DC%2BD2sXptlGksA%3D%3D 16773220 (Pubitemid 44782906)
53. AT Bergenheim J Capala M Roslin R Henriksson 2005 Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study J Neurooncol 71 287 293 10.1007/s11060-004-1724-0 1:CAS:528:DC%2BD28Xktg%3D%3D 15735919 (Pubitemid 40372959)
54. T Rhen JA Cidlowski 2005 Antiinflammatory action of glucocorticoids-new mechanisms for old drugs N Engl J Med 353 1711 1723 10.1056/NEJMra050541 1:CAS:528:DC%2BD2MXhtFansrrI 16236742 (Pubitemid 41464710)
55. Kesari S, Paleologos NA, Vick NA (2008) Corticosteroids in neuro-oncology. In: Schiff D, Kesari S, Wen PY (eds). Current clinical oncology: cancer neurology in clinical practice, 2nd edn. Humana Press, Totowa, NJ, pp 47-56
56. TR Brophy J McCafferty JH Tyrer MJ Eadie 1983 Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients Eur J Clin Pharmacol 24 103 108 10.1007/BF00613935 1:CAS:528:DyaL3sXhsFGgtr0%3D 6832191 (Pubitemid 13181792)
57. BT O'Sullivan DJ Cutler GE Hunt C Walters GF Johnson ID Caterson 1997 Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects Biol Psychiatry 41 574 584 10.1016/S0006-3223(96)00094-7 9046990 (Pubitemid 27145544)
58. JB Chalk K Ridgeway T Brophy JD Yelland MJ Eadie 1984 Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients J Neurol Neurosurg Psychiatry 47 1087 1090 10.1136/jnnp.47.10.1087 1:STN:280:DyaL2M%2FlslSjug%3D%3D 6502166 (Pubitemid 14006191)
59. MJ Fulham A Brunetti L Aloj R Raman AJ Dwyer G Di Chiro 1995 Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids J Neurosurg 83 657 664 10.3171/jns.1995.83.4.0657 1:CAS:528:DyaK2MXpsVSgtbo%3D 7674016
60. PJ Hutchinson MT O'Connell A Seal J Nortje I Timofeev PG Al-Rawi JP Coles TD Fryer DK Menon JD Pickard KL Carpenter 2009 A combined microdialysis and FDG-PET study of glucose metabolism in head injury Acta Neurochir (Wien) 151 51 61 10.1007/s00701-008-0169-1
61. MF Saad MG Riad-Gabriel A Khan A Sharma R Michael SD Jinagouda R Boyadjian GM Steil 1998 Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity J Clin Endocrinol Metab 83 453 459 10.1210/jc.83.2.453 1:CAS:528:DyaK1cXhtVSgtbc%3D 9467557 (Pubitemid 28496522)
62. C Simon L Weibel G Brandenberger 2000 Twenty-four-hour rhythms of plasma glucose and insulin secretion rate in regular night workers Am J Physiol Endocrinol Metab 278 E413 E420 1:CAS:528:DC%2BD3cXhvV2qtLc%3D 10710495
63. GA Breen J de Vellis 1974 Regulation of glycerol phosphate dehydrogenase by hydrocortisone in dissociated rat cerebral cell cultures Dev Biol 41 255 266 10.1016/0012-1606(74)90304-2 1:CAS:528:DyaE2MXptlChtA%3D%3D 4548877
64. JF McGinnis J De Vellis 1974 Cortisol induction of glycerol phosphate dehydrogenase in a rat brain tumour cell line Nature 250 422 424 10.1038/250422a0 1:CAS:528:DyaE2cXls1eku7s%3D 4368539
65. PJ Hutchinson MT O'Connell J Nortje P Smith PG Al-Rawi AK Gupta DK Menon JD Pickard 2005 Cerebral microdialysis methodology-evaluation of 20 kDa and 100 kDa catheters Physiol Meas 26 423 428 10.1088/0967-3334/26/4/008 1:STN:280:DC%2BD2MvlsVantw%3D%3D 15886437 (Pubitemid 40768140)
66. K Brew D Dinakarpandian H Nagase 2000 Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 267 283 1:CAS:528:DC%2BD3cXhsFGktbs%3D 10708863
67. E Van Meir Y Sawamura AC Diserens MF Hamou N de Tribolet 1990 Human glioblastoma cells release interleukin 6 in vivo and in vitro Cancer Res 50 6683 6688 2208133
68. A Kawashima T Harada K Imada T Yano K Mizuguchi 2008 Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma Prostaglandins Leukot Essent Fatty Acids 79 59 65 10.1016/j.plefa.2008.07.002 1:CAS:528:DC%2BD1cXhtFansbzK 18762411
69. A Sasaki S Ishiuchi T Kanda M Hasegawa Y Nakazato 2001 Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines Brain Tumor Pathol 18 13 21 10.1007/BF02478920 1:CAS:528:DC%2BD3MXnslSrt7c%3D 11517969
70. YM Lin HJ Jan CC Lee HY Tao YL Shih HW Wei HM Lee 2008 Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism Eur J Pharmacol 593 1 9 10.1016/j.ejphar.2008.06.111 1:CAS:528:DC%2BD1cXhtVens7bK 18652821
71. C Forster T Kahles S Kietz D Drenckhahn 2007 Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND J Physiol 580 937 949 10.1113/jphysiol.2007.129007 17317742 (Pubitemid 46915250)
72. G Ronquist R Hugosson U Sjolander U Ungerstedt 1992 Treatment of malignant glioma by a new therapeutic principle Acta Neurochir (Wien) 114 8 11 10.1007/BF01401106 1:STN:280:DyaK383itFyntg%3D%3D
73. K Garber 2006 Energy deregulation: licensing tumors to grow Science 312 1158 1159 10.1126/science.312.5777.1158 1:CAS:528:DC%2BD28XltFyntrs%3D 16728625
74. A Helmy KL Carpenter PJ Hutchinson 2007 Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs Curr Med Chem 14 1525 1537 10.2174/092986707780831113 1:CAS:528:DC%2BD2sXmtVWmtLk%3D 17584061 (Pubitemid 46902213)
75. JO Blakeley J Olson SA Grossman X He J Weingart JG Supko 2009 Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study J Neurooncol 91 51 58 10.1007/s11060-008-9678-2 1:CAS:528:DC%2BD1MXjvFyluw%3D%3D 18787762